文献速递生殖医学妇科

输卵管上皮细胞表达雄激素受体且与子宫内膜上皮相比具有独特的激素反应性

Fallopian tube epithelial cells express androgen receptor and have a distinct hormonal responsiveness when compared with endometrial epithelium.
PubMed 文献 · Hum Reprod · 2020-01-01

该前瞻性观察研究纳入47例因良性妇科疾病行子宫切除术及双侧附件切除术的已生育女性,比较输卵管与子宫内膜上皮的类固醇受体表达、增殖活性及体外对雌二醇和双氢睾酮的反应。结果显示输卵管上皮Ki67阳性细胞比例显著低于子宫内膜功能层腺体,而AR免疫评分显著更高,体外培养提示输卵管对雌二醇反应较弱、对双氢睾酮更敏感。

要点

  • 输卵管上皮Ki67阳性细胞比例显著低于配对子宫内膜功能层腺体(2.8%±2.2% vs 30.0%±26.3%,P=0.0018)。
  • 输卵管上皮AR免疫评分显著高于子宫内膜(6.7±2.7 vs 0.3±1.0,P=0.0136)。
  • 体外实验提示输卵管外植体对雌二醇反应较弱、对双氢睾酮更敏感。

核心结论

  • 人输卵管上皮的增殖指数、激素受体表达评分及体外对雌激素和雄激素的反应与配对子宫内膜呈现不同模式。

研究设计与样本

  • 前瞻性观察研究,纳入2010年至2018年在利物浦女性NHS基金会信托因良性妇科疾病行子宫切除术及双侧附件切除术的已生育女性,共47例(37例绝经前,10例绝经后),每例采集全层子宫内膜和输卵管样本。

主要发现

  • 绝经前子宫内膜功能层腺体显示已知的周期性增殖和类固醇受体评分变化。
  • 与配对子宫内膜功能层腺体相比,输卵管上皮(伞端或峡部端)Ki67阳性细胞比例显著更低(2.8%±2.2%,n=18 vs 30.0%±26.3%,n=16,P=0.0018)。
  • 输卵管上皮AR免疫评分显著高于子宫内膜(6.7±2.7,n=16 vs 0.3±1.0,n=10,P=0.0136)。
  • 输卵管上皮Ki67阳性细胞比例和AR免疫评分分别与子宫内膜腔上皮正相关(r=0.62,P=0.005;r=0.68,P=0.003)。
  • 体外实验提示输卵管外植体对雌二醇反应较弱,而对双氢睾酮更敏感。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 组织外植体培养的短期体外性质可能不能代表子宫内膜和输卵管不同解剖区域在体内的行为。
  • 研究纳入较高比例的月经周期规律的较年长绝经前女性,可能影响将发现外推至更年轻人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How does steroid receptor expression, proliferative activity and hormone responsiveness of the fallopian tube (FT) epithelium compare to that of the endometrial epithelium? SUMMARY ANSWER: Proliferative indices, hormone receptor expression-scores and in vitro response to oestrogen and androgens of the human FT demonstrate a distinct pattern from the matched endometrium. WHAT IS KNOWN ALREADY: The FT epithelium exists as a continuum of the endometrium, and both express steroid hormone receptors. The ovarian steroid hormones regulate cyclical proliferation and regeneration of the endometrium, but their effects on steroid hormone receptor expression and proliferation in the FT have not yet been fully elucidated. STUDY DESIGN, SIZE, DURATION: We included women with proven fertility, undergoing hysterectomy and bilateral salpingo-oophorectomy for benign, gynaecological conditions at Liverpool Women's NHS Foundation Trust. They had no known endometrial or tubal pathology and were not on hormonal treatments for at least 3 months preceding sample collection in this prospective observational study (conducted between 2010 and 2018). A full-thickness sample of the endometrium and a sample from the FT were collected from each woman. PARTICIPANTS/MATERIALS, SETTING, METHODS: The differential protein and mRNA levels of steroid hormone receptors, oestrogen receptors α and β, androgen receptor (AR) and progesterone receptor (PR), and the proliferative marker (Ki67) of the endometrium and the FT tissue samples from 47 healthy women undergoing surgery (37 premenopausal and 10 postmenopausal) were investigated using immunohistochemistry and quantitative real-time PCR. The comparative responsiveness to oestrogen and androgen of the endometrium and the fimbrial end of the FT was analysed using an in vitro short-term explant culture model. The endpoints assessed in the explants were the changes in mRNA and protein levels for AR, PR and the epithelial proliferative index after 24 h treatment with oestradiol (E2) or dihydrotestosterone (DHT). MAIN RESULTS AND THE ROLE OF CHANCE: The premenopausal endometrial functionalis glands (FG) displayed the well-known cyclic variation in cellular proliferation and steroid receptor scores. Compared with the endometrial FG, the matched FT epithelium (both fimbrial or isthmic ends) displayed a significantly lower proportion of cells expressing Ki67 (2.8% ± 2.2%, n = 18 vs 30.0% ± 26.3%, n = 16, P = 0.0018, respectively) accompanied with a significantly higher AR immunoscores (6.7 ± 2.7, n = 16 vs 0.3 ± 1.0, n = 10, P = 0.0136). The proportion of cells expressing Ki67 and the AR immunoscores of the FT epithelium correlated positively with endometrial luminal epithelium (r = 0.62, P = 0.005, and r = 0.68, P = 0.003, respectively). In vitro experiments suggested the tubal explants to be apparently less responsive to E2 yet more sensitive to DHT compared with the matched endometrium explants. LIMITATIONS, REASONS FOR CAUTION: The short-term in vitro nature of the tissue explant cultures used in the study may not be representative of how different anatomical regions of the endometrium and FT behave in vivo. Our study included a high proportion of older premenopausal women with a regular menstrual cycle, which may therefore affect extrapolation of findings to a younger group. WIDER IMPLICATIONS OF THE FINDINGS: Advancing our understanding of tubal and endometrial epithelial cell function has important implications for the diagnosis and treatment of diseases such as infertility, ectopic pregnancy, endometriosis and cancer. STUDY FUNDING/COMPETING INTEREST(S): The work included in this article was funded by Wellbeing of Women project grants RG1073 and RG2137 (D.K.H.) and Wellbeing of Women Entry-Level Scholarship ELS706 (A.M). A.M. was also supported by an NIHR ACF fellowship grant. Further support received from Liverpool Women's Hospital NHS Trust (S.M.), University of Liverpool (E.B. and A.W.). All authors declare there are no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Maclean A, Bunni E, Makrydima S, et al. Fallopian tube epithelial cells express androgen receptor and have a distinct hormonal responsiveness when compared with endometrial epithelium. Hum Reprod. 2020. PMID: 32876325. doi:10.1093/humrep/deaa177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。